Pharmaceutical News

RSS

IGDRASOL to present updates on Cynviloq at AACR annual meeting

Sorrento Therapeutics, Inc. and IGDRASOL announced today that IGDRASOL will be presenting updates of its development of Cynviloq (IG-001) at the annual meeting of the American Association for Cancer Research in Washington, DC (April 6th to 10th).

1 Apr 2013

Biological psychiatry shares progress in identifying genomic predictors of antidepressant response

Antidepressants are commonly prescribed for the treatment of depression, but many individuals do not experience symptom relief from treatment.

30 Mar 2013

New technique for vaccine design could prove useful against HIV, other viral strains

A team led by scientists from The Scripps Research Institute (TSRI) and the International AIDS Vaccine Initiative (IAVI) has unveiled a new technique for vaccine design that could be particularly useful against HIV and other fast-changing viruses.

30 Mar 2013

Recent findings reveal correlations between autism prevalence, childhood vaccination

Recent finds in two articles in the Journal of Toxicology and Environmental Health, Part A indicate correlations between autism and vaccinations.

30 Mar 2013

Study highlights cost savings of generic drugs

Consumer Reports offers new analysis that finds not all patients realize they can save big by shopping around for drugs. Meanwhile, two outlets look at insurance coverage issues for couples.

30 Mar 2013

Researchers find no association between receiving too many vaccines too soon and autism

Although scientific evidence suggests that vaccines do not cause autism, approximately one-third of parents continue to express concern that they do; nearly 1 in 10 parents refuse or delay vaccinations because they believe it is safer than following the Centers for Disease Control and Prevention's schedule.

30 Mar 2013

Invokana tablets receive FDA approval to treat adults with type 2 diabetes

The U.S. Food and Drug Administration today approved Invokana (canaglifozin) tablets, used with diet and exercise, to improve glycemic control in adults with type 2 diabetes.

30 Mar 2013

GE Healthcare seeks approval to supply Optison to EU market from Oslo manufacturing facility

GE Healthcare today announced that it has submitted an application to amend its European Marketing Authorisation that will allow the company to manufacture Optison 0.19 mg/ml dispersion for injection within its own facility.

30 Mar 2013

FDA approves Teva's Quartette tablets for prevention of pregnancy

Teva Pharmaceutical Industries Ltd. today announced that the U.S. Food and Drug Administration has approved Quartette (levonorgestrel/ethinyl estradiol and ethinyl estradiol) tablets for the prevention of pregnancy.

30 Mar 2013

Medivir seeks FDA approval for simeprevir

Medivir AB today announced that a new drug application has been filed with the U.S. Food and Drug Administration seeking approval for simeprevir.

30 Mar 2013

Parents, officials in Pakistan working to bring polio vaccine to areas under militant control

"Parents and officials are going to great lengths to immunize children after militants imposed a ban on polio vaccinations in Pakistan's restive North Waziristan Agency," with some parents "traveling long distances to get their children vaccinated" or "smuggling the vaccine back home," IRIN reports.

30 Mar 2013

Correctional policies discourage released inmates from seeking methadone therapy, researchers say

Methadone treatment for opioid dependence remains widely unavailable behind bars in the United States, and many inmates are forced to discontinue this evidence-based therapy, which lessens painful withdrawal symptoms.

30 Mar 2013

South Africa to host third global forum on TB vaccines

"This week more than 250 scientists, researchers, and tuberculosis (TB) advocates from all over the world will gather in Cape Town, South Africa, at the Third Global Forum on TB Vaccines to share findings and look to the future of TB vaccine research and development,"

29 Mar 2013

Study: Diabetes drug slows down ageing process by mimicking the effects of dieting

A widely prescribed type 2 diabetes drug slows down the ageing process by mimicking the effects of dieting, according to a study published today using worms to investigate how the drug works.

29 Mar 2013

New evidence shows older adults with dementia can be taken off antipsychotic medications

Most older adults with dementia can successfully be taken off antipsychotic medications, which have negative side effects and increase the risk of death, finds a new evidence review from The Cochrane Library.

29 Mar 2013

Drug costs and pricing issues touch hospitals, independent pharmacies

NPR reports on how one hospital made what is termed an "unusual decision" -- it chose to not stock a new drug because it was very costly.

29 Mar 2013

Study explores a better alternative for treating bipolar disorder

Toxicity problems and adverse side effects when taking lithium, the mainstay medication for treating bipolar disorder, are fostering a scientific hunt for insights into exactly how lithium works in the body - with an eye to developing a safer alternative.

28 Mar 2013

TSRI scientists receive innovative grant to help people break nicotine addiction

As part of an unprecedented national effort to develop new drugs to treat neurological disorders, scientists from the Florida campus of The Scripps Research Institute (TSRI) have been awarded an innovative grant from the National Institute of Neurological Disorders and Stroke to help people break their addiction to nicotine.

28 Mar 2013

First Edition: March 28, 2013

Today's headlines include various stories about the health law's implementation at both the federal and state level.

28 Mar 2013

European Commission grants conditional marketing authorization for Pfizer's BOSULIF

Pfizer Inc. announced today that the European Commission has granted conditional marketing authorization for BOSULIF (bosutinib) in the European Union for the treatment of adult patients with chronic phase, accelerated phase and blast phase Philadelphia chromosome positive chronic myelogenous leukemia previously treated with one or more tyrosine kinase inhibitor(s) and for whom imatinib, nilotinib and dasatinib are not considered appropriate treatment options.

28 Mar 2013

Pharmaceutical News

IGDRASOL to present updates on Cynviloq at AACR annual meeting

Biological psychiatry shares progress in identifying genomic predictors of antidepressant response

New technique for vaccine design could prove useful against HIV, other viral strains

Recent findings reveal correlations between autism prevalence, childhood vaccination

Study highlights cost savings of generic drugs

Researchers find no association between receiving too many vaccines too soon and autism

Invokana tablets receive FDA approval to treat adults with type 2 diabetes

GE Healthcare seeks approval to supply Optison to EU market from Oslo manufacturing facility

FDA approves Teva's Quartette tablets for prevention of pregnancy

Medivir seeks FDA approval for simeprevir

Parents, officials in Pakistan working to bring polio vaccine to areas under militant control

Correctional policies discourage released inmates from seeking methadone therapy, researchers say

South Africa to host third global forum on TB vaccines

Study: Diabetes drug slows down ageing process by mimicking the effects of dieting

New evidence shows older adults with dementia can be taken off antipsychotic medications

Drug costs and pricing issues touch hospitals, independent pharmacies

Study explores a better alternative for treating bipolar disorder

TSRI scientists receive innovative grant to help people break nicotine addiction

First Edition: March 28, 2013

European Commission grants conditional marketing authorization for Pfizer's BOSULIF

How agentic AI is reshaping laboratory workflows

Fourier 80: bringing benchtop NMR systems to the laboratory

How industrial hygiene flow calibration supports defensible exposure data

Latest News